Taisho Pharmaceutical Holdings Co Ltd (4581.T)
17 May 2019
Latest Key Developments (Source: Significant Developments)
Dec 16 (Reuters) - :TAISHO IS SAID TO NEAR $1.6 BILLION DEAL FOR BRISTOL-MYERS'S UPSA UNIT - BLOOMBERG, CITING SOURCES. Full Article
June 27 (Reuters) - Biofermin Pharmaceutical Co Ltd <4517.T>:Says it names Hideyuki Waki as president, effective June 27 . Full Article
Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.